Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy

Clinical trial NCT00707655 · TERMINATED

Trial details

NCT number: NCT00707655
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Carcinoma

Start date: 2008-09-01
Primary completion: 2010-10-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.